A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Clinical trial NCT01447706 · COMPLETED

Trial details

NCT number: NCT01447706
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer

Start date: 2011-10-01
Primary completion: 2013-09-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.